Oral nifedipine versus labetalol in treatment of postpartum hypertensio

Phase 1

• Conditions: Hypertension; O13; Gestational [pregnancy-induced] hypertension

• Registration Number: DRKS00014081
• Lead Sponsor: prof ob& gyn

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2018-03-12
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

Women who have hypertension during pregnancy and persist after delivery till discharge of hospital

Exclusion Criteria

Women with history of secondary hypertension
Women with eclampsia who need intensive care unit admission and indicated other drugs rather than oral nifedipine and oral labetalol
Women who have any contraindication to Nifedipine or labetalol

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Duration and total dose to achieving blood pressure below the critical value between 140 and 150 mmHg systoloic and 90-100 mmHg diastolic till discharge of hospital about two days

Secondary Outcome Measures

Name	Time	Method
Resolution of complications<br>Improvement of heamatological values and other investigations <br>Side effects in both groups